Purpose Wild blueberries (WB) (Vaccinium angustifolium) are rich sources of polyphenols, such as flavonols, phenolic acids and anthocyanins (ACNs), reported to decrease the risk of cardiovascular and degenerative diseases. This study investigated the effect of regular consumption of a WB or a placebo (PL) drink on markers of oxidative stress, inflammation and endothelial function in subjects with risk factors for cardiovascular disease. Methods Eighteen male volunteers (ages 47.8 ± 9.7 years; body mass index 24.8 ± 2.6 kg/m 2 ) received according to a cross-over design, a WB (25 g freeze-dried powder, providing 375 mg of ACNs) or a PL drink for 6 weeks, spaced by a 6-week wash-out. Endogenous and oxidatively induced DNA damage in blood mononuclear cells, serum interleukin levels, reactive hyperemia index, nitric oxide, soluble vascular adhesion molecule concentration and other variables were analyzed.
Introduction
Dietary habits and lifestyle in general are major risk and/or protective factors in the development and progression of degenerative diseases. The incidence of cardiovascular disease (CVD) as well as the prevalence of the metabolic syndrome is increasing worldwide [1] . As a consequence, costs for health care are rising and there is a strong demand for preventive strategies that can be easily implemented by the majority of the population. Diets rich in fruits and vegetables are among the recommended lifestyle modifications to decrease the risk of CVD, but they can also reduce the complications associated with aberrant metabolic states or already established disorders [2] . There is increased interest in the nutritional and functional aspects of berries (e.g., blackberry, bilberry, blackcurrant, cranberry, strawberry and blueberry) that can be consumed as fresh or processed foods [3] [4] [5] . They contain high amounts of flavonoids and phenolic acids that may be important components for a plethora of biological processes [6, 7] . Wild or lowbush blueberries (Vaccinium angustifolium) are rich sources of anthocyanins (ACNs) that have high antioxidant capacity as demonstrated in vitro, in animal models and in humans [8] [9] [10] . Anthocyanins have been demonstrated to have a positive impact on inflammation, hyperglycemia, lipid metabolism, fat deposition, endothelial function, and to decrease the oxidative damage of macromolecules [11] [12] [13] [14] [15] [16] [17] [18] . However, the study of the mechanisms by which wild blueberries contribute to the beneficial health effects remains quite difficult since ACNs are poorly absorbed (within 1-3 h) and are rapidly metabolized and excreted within 12-24 h after consumption [19] . The protective effect of wild blueberry intake has been studied in several animal models in our laboratories [12, [20] [21] [22] [23] [24] [25] . In particular, we have demonstrated that the intake of wild blueberries (24 mg ACNs per day) can improve vasomotor tone in the rat aorta and lymphocyte resistance against oxidatively induced DNA damage [21, 22] . However, it is important to validate the observations from animal models with controlled human interventions to determine the protective effect of wild blueberries on a wide range of biomarkers especially in subjects with CVD risk factors. To our knowledge, there is a paucity of studies that have evaluated the in vivo effect of blueberry consumption in humans with risk factors for CVD [16, 26] . The aim of the present human intervention study was to investigate the hypothesis that regular intake of a wild blueberry drink for 6 weeks could improve peripheral endothelial function (measured by reactive hyperemia arterial tonometry), biomarkers of oxidative stress (e.g., DNA damage and repair), lipid profile, and inflammatory markers in subjects with at least one risk factor for CVD.
Materials and methods

Recruitment of subjects
Subjects involved in the study were recruited from the staff of the University of Milan and other Institutes through advertisement on bulletin boards. Only male subjects were included in the study to avoid effects related to hormonal fluctuation during the various phases of the menstrual cycle [27] . Inclusion criteria were as follows: healthy subjects with at least one risk factor for CVD based on American Heart Association guidelines [28] , such as pre-hypertension (systolic pressure 120-139 mm Hg and diastolic pressure between 80 and 89 mm Hg), high total serum cholesterol (TSC) (C5.17 mmol/L), low high-density lipoprotein (HDL) cholesterol (\1.03 mmol/L), high lowdensity lipoprotein (LDL) cholesterol (C3.36 mmol/L), high triglycerides (TG) (C1.69 mmol/L), overweight (BMI C 25 kg/m 2 ) and smoking ([10 cigarettes/day). Individuals with secondary hypertension or obesity (BMI C 30) were excluded. A medical history questionnaire was used to exclude subjects with diseases such as diabetes, renal insufficiency, known food allergies, chronic constipation, diarrhea or any other gastrointestinal problem or disease. Subjects were specifically excluded from the study if they were taking drugs, dietary supplements, specific probiotics, prebiotics or medications during the last month before the beginning of the experiment. Weight and height were assessed and subjects were selected on the basis of an interview to evaluate their dietary habits and ensure that they were as homogeneous as possible, in particular for fruit and vegetable consumption. This was obtained by means of a food frequency questionnaire previously published and specifically revised to focus on food sources rich in antioxidants [29] . Other exclusion criteria were as follows: high ([5 portions/day) or low (\2 portions/day) intake of fruit and vegetables and habitual alcohol consumption (\3 drinks per week). Volunteers who followed a specific diet, such as vegetarian, vegan or macrobiotic, and those who had a specific aversion to blueberries or their products, were excluded. Twenty male subjects, aged 47.8 ± 9.7 years with BMI 24.8 ± 2.6 kg/m 2 were selected. The study was performed in accordance with the ethical standards according to the 1964 Declaration of Helsinki and was approved by the Ethics Committee of the University of Milan. All participants signed the informed consent form.
Blueberry and placebo drink preparation
The wild blueberry (WB) drink was prepared by suspending 25 g of WB freeze-dried powder (i.e., a composite from Wayman's (Cherryfield, ME), standardized at 1.5 % total ACNs by FutureCeuticals (Momence, IL, USA)) in 250 mL of water to give an amount of WB equivalent to 1 cup of raw fruits (148 g, providing approximately 375 mg of ACNs). The nutritional composition of the soluble WB powder used in the study is reported in Table 1 . The placebo (PL) drink was prepared to have sensory characteristics similar to the WB drink but not to contain polyphenols. The PL drink consisted of 250 mL water, 7.5 g fructose, 7 g glucose, 0.5 g citric acid and 0.03 g blueberry flavor (Kerry Ingredients & Flavours Italia S.p.A., Bergamo, Italy). In order to reach the same color, small amounts of food colors typically used by food industry for the production of soft drinks were added to the PL drink. The microbiological and chemical stability of the two drinks was evaluated. Microbiological stability was ensured for 72 h. Analysis of ACNs documented that their content in the WB drink decreased by about 20 % after 24 h and by about 35 % after 48 h at 4°C.
Experimental design
A randomized, repeated-measures crossover design was utilized. Subjects were randomly divided (by using a computer random number generator) into two groups of ten subjects each: group 1 was assigned to the sequence WB drink/wash-out/PL drink, whereas group 2 followed the sequence PL drink/wash-out/WB drink. WB and PL drinks were consumed daily for 6 weeks; the two treatments were separated by a 6-week wash-out period. Subjects received each morning the freshly prepared WB or PL drink in appropriate iceboxes. Participants were instructed to keep the drink under refrigeration, to avoid exposing it to a heat source or light and consume the drink within the morning. Additionally, participants were asked to mix the beverage very well before drinking, rinse out each bottle with water and drink it to ensure complete intake of the WB powder. Every Friday, subjects received the drinks for the week-end and kept them refrigerated. Subjects were instructed to maintain their normal dietary and lifestyle habits (as declared before enrollment) but to abstain from consuming berries and other ACN-rich food sources. For this reason, during the experimental period, each subject received a complete list of foods high in ACNs to be avoided. A 24-h Anthocyanin and phenolic acid extraction and analysis in the wild blueberry powder by LC-DAD-MS/MS
The liquid chromatography/diode array detector/mass spectrometry (LC-DAD-MS/MS) analysis of ACNs in the WB powder was performed in accordance with a procedure previously published [20] . Briefly, the WB powder (250 g) was suspended in 1 % trifluoroacetic acid (TFA) aqueous solution, and extraction was performed through sonication. After centrifugation, the supernatant was injected in the LC system for the analysis. Phenolic acids were extracted as previously described. The high-performance liquid chromatography (HPLC) analysis was performed with a system equipped with an Alliance mod 2695 (Waters, Milford, MI, USA) and a mod 2996 photo diode array detector (Waters). Chromatographic data were acquired using an Empower workstation (Waters). The analytical column was a 5-lm C 18 Vydac 201TP54 (250 mm 9 4.6 mm, i.d.; Esperia, CA, USA) with biocompatible frits. The eluents were (A) phosphoric acid (0.1 %) and (B) methanol/acetonitrile/ water/phosphoric acid (22.5/22.5/55/0.1) at a flow rate of 1.5 mL/min. The calibration curves were in the range of 1-10 lg/mL. Visible detection was achieved at 320 nm.
Soluble and insoluble fiber analysis in the wild blueberry powder
Soluble and insoluble dietary fiber in the WB powder was determined by the AOAC (Association of Official Analytical Chemists) International method 991.43; an AACC (American Association for Clinical Chemistry) 46.13 was used for the determination of protein in the residue [30] .
Sample collection and separation
Blood was collected early in the morning by a phlebotomist. Samples were drawn into evacuated tubes with or without heparin. Plasma was separated within 30 min after collection and serum within 1 h, by centrifugation for 15 min at 2,3009g at 4°C. Blood mononuclear cells (BMCs) were obtained from whole blood by density gradient centrifugation with Histopaque 1077 (Sigma Chemicals Co., St. Louis, MO). Blood mononuclear cells were removed from the gradient, washed with phosphate-buffered saline (PBS) and used for the determination of endogenous cell resistance to H 2 O 2 -induced DNA damage. An aliquot of BMCs was isolated and dissolved into an appropriate medium (90 % RPMI media, 10 % dimethyl sulfoxide, Sigma) and stored at -80°C until the evaluation of repair activity. Red blood cells were obtained from whole blood by centrifugation at 2,3009g for 10 min and were washed with an equal volume of PBS solution. Red blood cells (1 mL) were diluted with ice water (1:4) and centrifuged at 10,0009g for 10 min. All samples were then aliquoted and stored at -80°C until the determination of hemoglobin and evaluation of SOD and GSH-Px activities. Red blood cells (500 lL) used for glutathione analysis were acidified with an equal solution of metaphosphoric acid (10 %) before storage.
Analysis of biochemical parameters
A general laboratory biochemical assessment was made including the evaluation of hepatic and renal function (serum creatinine, AST, ALT and GGT), lipid profile (TG, TSC and HDL-C) and glucose [31] . All these parameters were determined using standard laboratory methods. LDL-C was calculated using the Friedewald's method. Plasma IL-6, TNF-a, CRP and s-VCAM 1 concentrations were measured by Quantikine human colorimetric sandwich ELISA immunoassay kits (R&D Systems, Inc. Minneapolis, MN). Plasma concentration of total NO was calculated by measuring the products of oxidation (nitrate and nitrite) by a Fluorometric Assay Kit (Cayman Chemical, Ann
Arbor, MI). Lymphocyte GST activity analysis was performed in accordance with the procedure described previously [32] . GST activity was standardized to milligrams of protein and determined using a BCA TM Protein Assay Kit (Pierce, Rockford, IL, USA). SOD and GSH-Px activities were measured in erythrocytes using commercial kits (Cayman chemical, Ann Arbor, USA). Enzyme activities were standardized to milligrams of hemoglobin determined by the use of Drabkin's reagent (Sigma Diagnostic, Co., St. Louis, MO). Vitamin C was determined in plasma by HPLC analysis as previously published [18] . Vitamin B 12 and total folate were measured by competitive immunoassay using direct chemiluminescence [31] . Analysis of GSH and GSSG in the erythrocyte lysate was performed following the instructions reported in a commercially available kit (Cayman chemical, Ann Arbor, USA).
Anthocyanin extraction and analysis in plasma
Two aliquots of plasma (1 mL) were acidified with TFA (1 %), vortexed and centrifuged for 1 min at 4,5009g, and the supernatant was stored at -80°C until analysis. Anthocyanins were extracted from plasma using a MicroPlate solid-phase extraction (SPE) HLB Oasys Cartridge pre-activated with methanol (500 lL) and washed with 500 lL acidified water (1 % TFA). Plasma (400 lL) was diluted with 140 lL of acidified water (1 % TFA) and 60 lL of water containing the internal standard (50 ng/mL of CydG). Plasma was vortexed, centrifuged and loaded onto the cartridge. The samples were drained under gravity, and the cartridge was washed with acidified water (100 lL; 1 % TFA) and 100 lL acidified MetOH (20 % TFA). The ACNs were eluted from the cartridge using 50 lL of methanol (70 %) containing TFA. The filtered sample was injected into UHPLC-MS/MS system for analysis according to the method previously published [20] .
Evaluation of peripheral vasoreactivity
Peripheral vasoreactivity was evaluated before blood drawing to avoid possible side effects on blood pressure and vasoactivity. Endothelial-dependent vasodilation in the small finger arteries was assessed by a non-invasive plethysmographic method (Endo-PAT2000, Itamar Medical Ltd., Caesarea, Israel) based on the registration of pulsatile blood volume in the fingertips of both hands. The Endo-PAT equipment consists of two finger-mounted probes, which include a system of inflatable latex air-cushions within a rigid external case; pulsatile volume changes of the fingertip are sensed by a pressure transducer, located at the end of each probe, and transferred to a personal computer where the signal is band-pass-filtered (0.3-30 Hz), amplified, displayed and stored. The Endo-PAT studies were performed with the patient in the supine position and both hands on the same level in a comfortable, thermoneutral environment. Arterial systolic and diastolic blood pressure and heart rate frequency were measured before starting the test. A blood pressure cuff was placed on one upper arm (study arm), while the contralateral arm served as a control (control arm). After a 10-min equilibration period, the blood pressure cuff on the study arm was inflated to 60 mmHg above systolic pressure for 5 min. The cuff was then deflated to induce reactive hyperemia (RH), whereas the signals from both PAT channels (Probe 1 and Probe 2) were recorded by a computer. The Reactive Hyperemia Index (RHI), an index of the endothelialdependent flow-mediated dilation (FMD), was derived automatically in an operator-independent manner, as the ratio of the average pulse wave amplitude during hyperemia (60-120 s of the post-occlusion period) to the average pulse wave amplitude during baseline in the occluded hand divided by the same values in the control hand and then multiplied by a baseline correction factor. A RHI value of 1.67 provides a sensitivity of 82 % and a specificity of 77 % for diagnosing endothelial dysfunction [33] . RHI has been shown to correlate with the ischemia-induced FMD in the larger brachial artery measured by high-resolution ultrasound and with the gold standard method (the acetylcholine infusion in coronary arteries) for the endothelial function assessment [34, 35] .
In addition to the RHI, we also report here, the Framingham RHI (FRHI), which was automatically calculated using, a different post-occlusion hyperemia period (90-120 s) without baseline correction factor. The FRHI, which has been shown to correlate with other CVD risk markers [36, 37] , was expressed as the natural log of the resulting ratio.
Finally, the EndoPAT device also generates the Augmentation Index (AI), a measure of vascular stiffness (pulse wave reflection) that is calculated from the shape of the pulse wave recorded by the probes during baseline. AI can be adjusted to a heart rate of 75 beats/min to correct for the independent effect of heart rate on this measure [38] .
Evaluation of DNA damage, repair activity and cell resistance against H 2 O 2 -induced DNA damage
The level of oxidized bases was determined as formamidopyrimidine DNA glycosylase (FPG)-sensitive sites in BMCs by the comet assay as described previously [39] . The FPG protein detects 8-oxo-7,8-dihydro-2 0 -deoxyguanosine (8-oxodG) and ring-opened formamidopyrimidine nucleobases. This analysis of oxidatively damaged DNA has been thoroughly validated in inter-laboratory validation trials and shows generally good concentration-response relationship with agents that preferentially generate 8-oxodG [40, 41] . The repair activity toward oxidatively damaged DNA was measured by the comet assay in substrate A549 cells treated with 1 lM Ro19-8022/white light, which generates 8-oxo-7,8-dihydroguanine. Cell extracts were incubated with substrate cells for 20 min at 37°C [42] . Cell resistance against oxidatively generated DNA damage (i.e., strand breaks and alkali-labile sites) was measured in freshly isolated BMCs treated with H 2 O 2 (500 lmol/L in PBS) for 5 min as described previously [43] . The levels of DNA damage were calculated as percentage of DNA in the tail. For each sample, the percentage of DNA in tail of control cells (not treated with H 2 O 2 or not incubated with FPG) was subtracted from the percentage of DNA in tail of H 2 O 2 -treated or FPG-incubated cells, respectively.
Statistical analysis
Sample size has been calculated taking into account the expected variation in the primary endpoints considered. In particular, twenty subjects were calculated to be sufficient to evaluate a difference in RHI after the WB drink of 0.28 (standard deviation 0.40), with alpha = 0.05 and a statistical power of 80 %. Moreover, the ''repeated-measure'' experimental design in which each subject acts as its own control allows to conduct the experiment more accurately, thus reducing the error variance.
Statistical analysis was performed by means of STAT-ISTICA software (Statsoft Inc., Tulsa, OK, US). The Shapiro-Wilk test was applied to verify the normal distribution of the variables. Data obtained were elaborated by analysis of variance (ANOVA) with the treatment sequence (WB drink vs PL drink or vice versa) as the independent factor in order to exclude the presence of carry-over effects. As none was detected, data were analyzed by ANOVA for repeated-measures design. ANOVA with treatment (WB drink vs PL drink) and time (before and after each treatment) as dependent factors was applied to evaluate the effect of the WB drink on the variables under study. The difference in responses to the WB and PL drink periods was evaluated by statistically significant p values for the interaction between treatment and time in the overall repeated ANOVA. Moreover, ANOVA with type of treatment as the dependent factor was used to evaluate percentage change [i.e. (after treatment-before treatment)/ before treatment *100] at the different endpoints of peripheral arterial function. The mean changes are described as mean with 95 % confidence interval (CI). Differences are considered significant at p B 0.05; post hoc analysis of differences between treatments was assessed by the least significant difference (LSD) test with p B 0.05 as level of statistical significance. Finally, a statistical analysis of data on peripheral arterial function and DNA damage was performed by considering a stratification according to the number of risk factors in the subjects enrolled. In particular, two classes were considered: class 1 (subjects with B2 risk factors) and class 2 (subjects with [2 risk factors).
Results
Composition and characteristics of the wild blueberry powder
The nutritional composition of the WB powder used for the study expressed for 100 g of product and 25 g (one portion) is reported in Table 1 . One portion of the WB powder provided about 102 kcal, 1.5 g of lipids, 1 g of proteins, 17 g of sugars (glucose and fructose) and 4.2 g of total fiber. The soluble fiber and insoluble fiber were 0.6 g and 3.6 g, respectively. Chlorogenic acid (127.5 mg/25 g) was the main phenolic acid detected in the WB powder. The total ACN concentration was 375 mg/25 g with peonidin-3-glucoside, malvidin-3-galactoside, delphinidin-3-glucoside and delphinidin-3-galactoside as the dominant ACN compounds, which represented about 35 % of the total amount of ACNs as previously reported [20] .
Baseline characteristics of the subjects Twenty people began the study and eighteen completed the whole protocol. Two subjects withdrew from the study due to personal reasons. Baseline anthropometric and clinical characteristics of the remaining 18 subjects are presented in Table 2 . Blood pressure, lipid profile and inflammatory markers were within the range of normality. According to the guidelines of the American Heart Association (28), 8 subjects were classified as overweight (BMI [ 25 kg/m 2 ), 7 had high levels of TSC (C6.2 mmol/L) and 7 were borderline high (5.17-6.18 mmol/L). Six subjects had high levels of LDL cholesterol (C4.13 mmol/L) and 7 were borderline high (3.36-4.11 mmol/L). Ten subjects were pre-hypertensive (systolic pressure 120-139 mm Hg and diastolic pressure between 80 and 89 mm Hg). Nine subjects were smokers/ex-smokers. Finally, eight subjects had below normal endothelium-dependent vasodilation with a RHI value B1.67.
Effect of intervention on dietary markers
The effect of the 6-week intervention with the WB vs the PL drink on dietary markers evaluated in plasma is reported in Table 3 . The intervention resulted in no significant effect on vitamin C, vitamin B 12 , folate, GSH and GSSG concentrations and GSH/GSSG ratio. No ACNs were detected in the plasma after the WB or PL drink treatment after 6 weeks of intervention.
Effect of intervention on vascular function and blood pressure
The values of RHI, FRHI, AI, AI@75, NO, sVCAM-1 and blood pressure are reported in Table 4 . One subject was omitted from the analysis due to abnormal values registered in 2 different time points. Vascular function of the subjects measured by Endo-PAT2000 did not improve significantly, according to the repeated-measures ANOVA, after the WB and PL drinks (p = 0.452 for the interaction between treatment and time). However, an apparent decrease in the RHI was observed during consumption of the PL drink with respect to WB drink. The mean percent change between the pre-to-post intervention was ?4.9 % (95 % CI: -11 %, ?20.8 %) after the WB drink and -4.9 % (95 % CI: -12.6 %, ?3.9 %) after the PL drink. On the whole, a high inter-individual variability was observed in the percent change of RHI ( Fig. 1 ) with about half of the subjects (53 %; 9 out of 17) having an improvement following the intervention with the WB drink, while the other half experienced (47 %; 8 out of 17) a decrease. In the placebo group, we observed that few subjects (23 %; 4 out of 17) had an improvement following the intervention with the PL drink, while more than a half of the subjects (59 %; 10 out of 17) showed a decrease. No effect was seen in the remaining subjects (18 %; 3 out of 17). No significant changes in FRHI, AI, AI@75, blood pressure (systolic and diastolic), total plasma NO and sVCAM-1 were documented after the 6-week intervention with the WB drink or the PL drink.
Effect of intervention on DNA damage and repair activity in blood mononuclear cells
Results on the levels of DNA damage and repair activity are shown in Table 5 . There was a significantly different treatment effect between the WB and PL drink periods (p = 0.039 for the interaction between treatment and time). Data are expressed as mean ± SD BMI body mass index, TG triglycerides, TSC total serum cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, nd not detectable, AST aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltransferase, ACNs anthocyanins, GSH reduced glutathione, GSSG oxidized glutathione, SOD superoxide dismutase, GST glutathione S-transferase, GSH-Px glutathione peroxidase, NO nitric oxide, sVCAM-1 vascular cell adhesion molecule-1, CRP C-reactive protein, IL-6 interleukin-6, TNF-a tumor necrosis factor alpha, RHI reactive hyperemia index, FRHI Framingham reactive hyperemia index, AI augmentation index, AI@75 augmentation index standardized for heart rate of 75 bpm Eur J Nutr (2013) 52:949-961 955
Estimation of oxidized purines in BMC DNA through quantification with the formamidopyrimidine DNA glycosylase (FPG)-sensitive sites indicated a statistically significant decrease following the WB drink (from 12.5 ± 5.6 % to 9.6 ± 3.5 %, p B 0.01) with respect to the PL drink (from 12.0 ± 4.5 % to 11.9 ± 4.4 %, p = 0.89). Moreover, there was also a significantly different treatment effect between the WB and PL drink periods (p = 0.037 for the interaction between treatment and time). The intake of the WB drink significantly decreased the levels of H 2 O 2 -induced DNA damage (from 45.8 ± 7.9 % to 37.2 ± 9.1 %, p B 0.01), while no effect was observed after the PL drink (from 44.9 ± 12.2 % to 44.4 ± 8.4 %, p = 0.84). Additionally, no significant effect was observed in DNA repair activity following the two treatments (WB vs PL drink).
Effect of intervention on anthropometric measures and biochemical parameters
Body weight, BMI and biochemical markers before and after the WB or PL drink are presented in Table 6 . The intervention had no significant effect on body weight and BMI, glucose, creatinine and enzyme activity (AST, ALT Data are expressed as mean ± SD; (n = 17 vascular function)
WB wild blueberry, PL placebo, RHI reactive hyperemia index, FRHI Framingham reactive hyperemia index, AI augmentation index, AI@75 augmentation index standardized for heart rate of 75 bpm, Total NO total nitric oxide, sVCAM-1 vascular cell adhesion molecules-1 a p values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, OK, US) Fig. 1 Individual values of reactive hyperemia index (RHI) measured by Endo-PAT2000 (Itamar Medical Ltd., Caesarea, Israel) and registered before and after six weeks of the WB drink and PL drink intake in the group of volunteers (n = 17). WB wild blueberry drink, PL placebo drink and GGT) in liver and SOD and GSH-Px activity in erythrocytes, and GST activity in lymphocytes of the subjects under study. No significant differences in lipid profile (TG, TSC, LDL-C and HDL-C) were observed following WB drink consumption.
Effect of intervention on biomarkers of inflammation
The plasma levels of IL-6, TNF-a and CRP of the subjects before and after the WB and PL drinks are reported in Table 7 . No significant difference in inflammatory markers was detected as a result of the intervention.
Effect of risk factor exposure on peripheral arterial function and levels of DNA damage Statistical analysis did not show differences in peripheral arterial function and levels of DNA damage before and after WB and PL drink based on the number of risk factors identified in the subjects: class 1 (subjects with B2 risk factors) and class 2 (subjects with [2 risk factors). When the subjects were classified as smokers/ex-smokers versus non-smokers, we observed that the reduction in the levels of H 2 O 2 -induced DNA damage after the WB intervention was higher: smokers/ex-smokers (44.4 ± 7.7 % vs 
Discussion
Most of the beneficial evidence on the modulation of endothelial function derives from experimental in vitro and ex vivo studies in which the vasoreactivity has been evaluated in the aorta of animals with invasive methods [12, [21] [22] [23] [24] [25] 44] . The evaluation of the peripheral arterial function, as a marker of CVD risk, is a relatively new approach and only few human studies investigated the impact of polyphenol-rich foods on this parameter [45] [46] [47] [48] . Some studies have demonstrated an improvement in peripheral arterial function, through Endo-PAT 2000, after the ingestion of a single dose of polyphenol-rich foods, in particular flavonol-rich foods/beverages such as cocoa [45] [46] [47] and chocolate [48] . The exploitation of the Endo-PAT device to evaluate the long-term effect of dietary interventions on vascular function merits further attention. To our knowledge, only one human intervention study investigated the effect of ACN-rich foods on the modulation of endothelial function in a medium-/long-term intervention. In this regard, Dohadwala et al. [49] demonstrated that 4 weeks of supplementation with cranberry juice (480 mL/day, providing 94 mg ACNs and 835 mg total polyphenols) had no effect on vascular function (measured by flow-mediated dilation in the brachial artery) in subjects with coronary artery disease. In the present study, we have demonstrated no significant difference in the peripheral arterial function in subjects with CVD risk factors, with about half of the subjects exhibiting an improvement following the intervention with the WB drink. No significant difference was also observed in blood pressure, s-VCAM-1 and total NO. The non significant effect of the WB drink on the modulation of peripheral arterial function may be attributed to the kinetics of wild blueberry ACNs and/or other polyphenols. It is widely recognized that ACNs are rapidly cleared from plasma after an oral dose of berry fruits with maximum bioavailability between 1 and 3 h [19] . In our study, ACNs were non-detectable in plasma after WB consumption, since blood samples were taken 12 h after the intake of the drink, when possibly ACNs were cleared from the circulation. However, many other factors may have affected our results such as the large inter-individual variation, individual differences in CVD risk factors, the duration of the intervention and the amount and form of the WB product. We provided our subjects with a dietary daily amount of ACNs through the WB drink since we were interested in studying a realistic condition. Future studies with larger numbers of subjects with homogeneous and/or more pronounced CVD risk factors or established endothelial dysfunction may show a beneficial effect of blueberry intervention. The effects of berries on oxidative stress have been investigated in different human intervention studies, but results are still inconclusive. Results from intervention studies with berries (single berry items or mixture of different berries) have documented a reduction in the levels of oxidatively damaged DNA evaluated by means of the comet assay [50, 51] , whereas other studies have reported no effect after the ingestion of ACN-rich blackcurrant juice or an ACN drink [52] . Under our experimental conditions, the WB drink reduced the level of oxidized DNA bases and increased the protection from the ex vivo H 2 O 2 -induced DNA damage. These results were particularly evident in the group of smokers/ex-smoker subjects with respect to non-smokers. This effect on DNA damage may be dependent on phytochemicals present in the WB drink that can exert a direct protective effect against oxidative insult by scavenging reactive oxygen species in blood. Moreover, ACNs may act through upregulation of the expression of different antioxidant genes involved in the detoxification of molecules such as hydrogen peroxide [53] . Other processes that may have been modulated by the WB drink could be alkylation or formation of ACN-DNA complexes, and/or modulation of DNA repair genes [54, 55] . In this regard, it has been reported that a flavonoid-rich diet could affect the expression of DNA repair genes belonging to different repair pathways like nucleotide excision repair, base Table 7 Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo (PL) drink on circulating levels of interleukin 6, tumor necrosis factor-a and C-reactive protein (n = 18) Data are expressed as mean ± SD WB wild blueberry, PL placebo, IL-6 interleukin-6, TNF-a tumor necrosis factor alpha, CRP C-reactive protein a p values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, OK, US) excision repair and double-strand breaks repair [55] . In our study, 6 weeks of WB drink consumption did not show an increase in DNA repair activity. In addition, no effect on SOD, GSH-Px or GST activity was observed, suggesting that upregulation of antioxidant enzymes is not the mechanism for the increased resistance toward H 2 O 2 -induced DNA damage. Studies on ingestion of polyphenol bioactive compounds have shown results on lipid profile data that are not univocal. Bilberries, blackcurrants, cranberry juice or extracts have shown a favorable effect on the lipid profile in dyslipidemic, hypercholesterolemic or metabolic syndrome subjects from improving HDL-C to lowering LDL-C and TG [56] [57] [58] [59] . On the contrary, Basu et al. [16] reported that 8 weeks of supplementation with a freeze-dried blueberry beverage (50 g of powder, providing 742 mg of ACNs per day) did not change the plasma lipid profile in subjects with the metabolic syndrome. Similarly, Stull et al. [26] found that the consumption of two blueberry smoothies per day (45 g of freeze-dried blueberry powder, providing 668 mg of ACNs) did not affect the lipid profile in obese subjects after 6 weeks of intervention. The above studies are in agreement with the present study, since the WB drink intervention did not alter the plasma lipid profile in subjects with risk factors for CVDs.
The role of berries in decreasing markers of inflammation has not been well investigated, and very few observations have shown an anti-inflammatory effect [26, 60] . Our results do not show a significant effect of the WB drink intake on the plasma levels of IL-6, TNF-a and CRP. These results are in accordance with other observations reported in the literature [16, 26, 60] . It should be noted that the inflammatory markers in our volunteers were in the normal physiologic concentration range at the onset of the study; thus, the potential of WB to affect such biomarkers may be more appropriately evaluated on subjects with high initial levels.
Conclusions
In conclusion, consumption of a WB drink, providing 375 mg of ACNs, for 6 weeks reduced the level of oxidized purines and improved the resistance against H 2 O 2 -induced DNA damage in BMCs. This indicates that regular consumption of wild blueberries can reduce oxidative stress in a relevant cell population in the blood, even though peripheral arterial function and the other variables studied here were not significantly affected. Future larger studies with a homogeneous population for CVD risk factors are necessary to understand the duration of exposure to ACNs and the dose and/or the form of the WB product that may be effective in modulating endothelial function and the other parameters studied.
